The biggest Medicare Part D changes for 2027 are a higher standard deductible of $700, a new out-of-pocket spending cap of $2,400 (after which your covered drugs cost you $0 for the rest of the year), and lower negotiated prices on 15 widely used medications — including the Ozempic (learn more about medicare supplement (medigap) plans explained: a 2026 guide to every plan) (learn more about what is medicare advantage? the complete guide to medicare part c (2026)) (learn more about the 12 best ways to live happy, healthy, and wealthy in retirement in 2026 and beyond) (learn more about complete guide to in-home care: aging in place with support) (learn more about tax planning guide: optimize your retirement tax strategy) (learn more about allianz index advantage annuity review: independent analysis (2026)) and Wegovy family. None of it happens automatically the way you want it to, though: your specific plan, premium, and drug list still change every year, so the single most important thing you can do is review your plan during Open Enrollment, October 15 through December 7.

If that feels like a lot to absorb, don't worry. Below is each change explained the way we'd explain it at the kitchen table — clearly, without the jargon, and without the scare tactics. Here are the six things worth knowing before 2027.

1. The deductible rises to $700

Every year, Medicare sets a standard deductible — the amount you pay out of pocket before your Part D plan starts sharing drug costs. For 2027, that standard deductible is $700, up from $615 in 2026.

A few things to keep in mind. First, this is the maximum standard deductible; some plans charge less, and a handful charge $0. Second, once you meet it, you move into the regular cost-sharing phase where you and your plan split the cost of covered drugs. If you take brand-name medications, you may reach the deductible in the first month or two of the year.

2. Your out-of-pocket costs are capped at $2,400

This is the change most seniors will actually feel in their wallet. In 2027, once your out-of-pocket spending on covered Part D drugs reaches $2,400, you pay nothing more for those drugs for the rest of the calendar year. The cap was $2,100 in 2026 and $2,000 in 2025.

The old "donut hole" coverage gap that used to leave people paying thousands is gone. For anyone managing a serious or chronic condition with expensive medications, this hard ceiling is real protection — you now know the most you'll spend in a year.

3. Fifteen more drugs get negotiated prices

Starting January 1, 2027, Medicare's negotiated prices take effect on a second group of 15 high-cost Part D drugs. The discounts range from about 38% to 85% off the previous list prices.

The list includes some of the most talked-about and widely used medications in the country:

• Ozempic, Rybelsus, and Wegovy (semaglutide) — used for type 2 diabetes, cardiovascular risk, and weight management. The negotiated Ozempic price is about $274 a month, down from a $959 list price.
• Trelegy Ellipta — a common asthma and COPD inhaler.
• Ibrance and Xtandi — cancer treatments.
• Linzess — for irritable bowel syndrome.
• Austedo — for Huntington's disease and tardive dyskinesia.

Roughly 5.3 million Medicare beneficiaries use these drugs, and the negotiated prices are expected to save about $685 million in out-of-pocket costs. By 2027, a total of 25 drugs will have negotiated prices, with more rounds coming in future years.

4. Lower list prices don't automatically mean lower copays

Here's the honest part. A negotiated price is what Medicare and your plan pay — it does not always translate one-for-one into a lower copay at the pharmacy counter. Your actual cost depends on which tier your plan places the drug on and how it structures cost-sharing.

That said, lower underlying prices tend to ease pressure on premiums and copays over time, and reaching that $2,400 cap becomes more meaningful when the drugs you rely on cost less along the way. The takeaway: check your specific plan's copay for your specific drug — don't assume.

5. Premiums and plan lineups will shift again

Part D isn't one government plan; it's dozens of private plans that reset their premiums, formularies (covered-drug lists), and pharmacy networks every year. A plan that was a great fit in 2026 may drop one of your medications, move it to a pricier tier, or raise its premium for 2027.

This is why longtime beneficiaries who "set it and forget it" sometimes overpay by hundreds of dollars a year. The plan didn't betray you — it simply changed, and the change wasn't flagged.

6. Open Enrollment is your one guaranteed window to act

You can compare and switch Part D plans during Medicare Open Enrollment, October 15 to December 7, with changes taking effect January 1, 2027. This is the time to make sure your plan still covers your medications at a price that makes sense.

A simple year-end checklist:

• List your current medications, including doses.
• Read your plan's Annual Notice of Change (it arrives in the fall) and note anything moving tiers or dropping off.
• Use the official Medicare Plan Finder at Medicare.gov to compare plans against your exact drug list.
• Confirm your pharmacy is still in-network — network changes quietly raise costs.
• Look at total annual cost, not just the monthly premium. A low premium with high copays can cost more overall.

The bottom line

For 2027, expect a $700 deductible, a $2,400 out-of-pocket cap, and meaningfully lower prices on 15 common drugs. Those are genuinely good developments for most people managing prescription costs. But the savings only reach you if your plan still fits — so treat the fall enrollment window as an annual tune-up, not an optional errand.

This article is for educational purposes only. SeniorSimple is not affiliated with or endorsed by Medicare or any government agency. For decisions about your coverage, review official information at Medicare.gov or speak with a licensed advisor.